Department of Obstetrics and Gynaecology, The University of Melbourne and Gynaecology Research Centre, Royal Women's Hospital, Melbourne, Victoria, Australia.
Department of Pathology, The Royal Women's Hospital, Melbourne, Victoria, Australia.
Hum Reprod. 2020 Dec 1;35(12):2701-2714. doi: 10.1093/humrep/deaa249.
Do menstrual cycle-dependent changes occur in the histological appearance of superficial peritoneal endometriotic lesions, and are they equivalent to those observed in the eutopic endometrium?
Only a small subset of superficial peritoneal endometriotic lesions exhibits some histological features in phase with menstrual cycle-related changes observed in eutopic endometrium.
Endometriotic lesions are frequently described as implants that follow menstrual cycle-related changes in morphology, as per the eutopic endometrium. This concept has been widely accepted despite the lack of conclusive published evidence.
STUDY DESIGN, SIZE, DURATION: This was a retrospective cohort study of 42 patients, from across the menstrual cycle, with surgically and histologically confirmed endometriosis. Patients were a subset selected from a larger endometriosis study being conducted at the Royal Women's Hospital, Melbourne since 2012.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Histological features of epithelium, stroma and gland morphology were examined in haematoxylin and eosin stained sections of superficial peritoneal endometriotic lesions and matched eutopic endometrium (menstrual: n = 4, proliferative: n = 11, secretory: n = 17, hormone-treated: n = 10). At least two biopsies (average = 4, range = 2-8 biopsies) and a matched endometrial sample were analysed for each patient and results were presented per endometriotic gland profile (n = 1051). Data were analysed using mixed effects logistic regression to account for multiple patients and multiple endometriotic biopsies, each with multiple endometriotic gland profiles. This model also enabled analysis of endometriotic lesions versus eutopic endometrium.
There was considerable inter- and intra-patient variability in the morphology of superficial peritoneal endometriotic lesions. Menstrual cycle-associated changes were only observed for some features in a subset of endometriotic gland profiles. The proportion of endometriotic gland profiles with epithelial mitoses significantly increased in the proliferative phase (18% of gland profiles) relative to the menstrual phase (0% of endometriotic gland profiles) (odds ratios (OR) 9.30; 95% confidence intervals (CI) = 3.71-23.32; P < 0.001). Fewer blood-filled gland lumens were observed in the secretory phase (45% of endometriotic gland profiles) compared to the menstrual phase (67% of endometriotic gland profiles) (OR, 0.30; 95% CI = 0.11-0.79; P = 0.015). The features of the eutopic endometrium analysed in this study did not reflect the results in matched endometriotic lesions (P > 0.05).
Not applicable.
LIMITATIONS, REASONS FOR CAUTION: This study focused on features observed in sections of superficial peritoneal lesions and these may differ from features of deep infiltrating endometriosis or ovarian endometriomas. Cycle phases were limited to menstrual, proliferative and secretory phases to allow appropriate statistical modelling.
This study highlights heterogeneity in the histological characteristics of superficial peritoneal lesions. It challenges the assumption that lesion morphology consistently reflects menstrual cycle-associated changes.
STUDY FUNDING/COMPETING INTEREST(S): Research reported in this publication was supported in part by National Health and Medical Research Council (NHMRC) project grants GNT1012245, GNT1105321 and GNT1026033 (P.A.W.R., J.E.G. and S.J.H.-C.). There are no competing interests.
浅表腹膜子宫内膜异位症病变的组织学外观是否存在与月经周期相关的变化,这些变化是否与在位子宫内膜的变化相当?
只有一小部分浅表腹膜子宫内膜异位症病变表现出一些与在位子宫内膜中观察到的与月经周期相关的变化相当的组织学特征。
子宫内膜异位症病变通常被描述为具有与形态学相关的月经周期变化的植入物,就像在位子宫内膜一样。尽管缺乏确凿的已发表证据,但这一概念已被广泛接受。
研究设计、大小、持续时间: 这是一项回顾性队列研究,纳入了 42 名患者,这些患者来自月经周期的各个阶段,通过手术和组织学证实患有子宫内膜异位症。这些患者是从墨尔本皇家妇女医院自 2012 年以来进行的一项更大的子宫内膜异位症研究中选择的亚组。
参与者/材料、设置、方法: 在苏木精和伊红染色的浅表腹膜子宫内膜异位症病变和匹配的在位子宫内膜切片中检查上皮、基质和腺体形态(月经期:n=4,增生期:n=11,分泌期:n=17,激素治疗期:n=10)。每个患者至少分析了 2 次活检(平均=4,范围=2-8 次活检)和 1 个匹配的子宫内膜样本,结果根据每个子宫内膜异位症腺体形态呈现(n=1051)。使用混合效应逻辑回归分析数据,以考虑多个患者和多个子宫内膜异位症活检,每个活检均有多个子宫内膜异位症腺体形态。该模型还能够分析子宫内膜异位症病变与在位子宫内膜之间的关系。
浅表腹膜子宫内膜异位症病变的形态存在很大的个体间和个体内变异性。仅在一些子宫内膜异位症腺体形态中观察到与月经周期相关的变化。增殖期的子宫内膜异位症腺体形态中上皮有丝分裂的比例明显增加(增生期 18%的腺体形态,月经期 0%的子宫内膜异位症腺体形态)(比值比(OR)9.30;95%置信区间(CI)=3.71-23.32;P<0.001)。与月经期(67%的子宫内膜异位症腺体形态)相比,分泌期的子宫内膜异位症腺体形态中血腔充满的腺体数量减少(45%的子宫内膜异位症腺体形态)(OR,0.30;95%CI=0.11-0.79;P=0.015)。在这项研究中分析的在位子宫内膜的特征与匹配的子宫内膜异位症病变的结果不一致(P>0.05)。
不适用。
局限性、谨慎的原因: 本研究集中在浅表腹膜病变切片中观察到的特征,这些特征可能与深部浸润性子宫内膜异位症或卵巢子宫内膜异位瘤的特征不同。周期阶段仅限于月经期、增生期和分泌期,以允许适当的统计建模。
这项研究强调了浅表腹膜病变组织学特征的异质性。它挑战了病变形态始终反映与月经周期相关的变化的假设。
研究资金/利益冲突: 本研究报告的研究得到了澳大利亚国家卫生和医学研究委员会(NHMRC)项目资助 GNT1012245、GNT1105321 和 GNT1026033(P.A.W.R.、J.E.G. 和 S.J.H.-C.)。没有利益冲突。